WARWICK, R.I. — January 17, 2012 — Biomedical Structures, LLC (BMS), a designer, developer and
manufacturer of biomedical textiles for medical devices and other advanced clinical applications,
today announced its new BIOFELT® absorbable scaffold for implant devices in orthopedics,
cardiology, and general surgery, as well as other in vivo applications. BIOFELT’s unique
non-woven structure provides a fibrous matrix platform that enables natural tissue in-growth in
surgical applications.
BIOFELT is a three dimensional non-woven structure with very high surface area and void
volume designed to promote natural cell adhesion and regeneration. Produced from PGA (Polyglycolic
Acid), PLLA (Poly L Lactic Acid) and copolymers such as PLGA (co-polylactic acid/glycolic acid),
BIOFELT can be used as a component of medical devices or surgical systems with the benefit of
bio-absorbability.
“BIOFELT is a terrific example of how traditional tissue engineering technology and materials
can be used in more innovative ways across medical device sectors,” said Dean Tulumaris, President
and CEO of BMS. “BMS’ commitment to emerging device development has long been one of our strengths,
and we dedicate tremendous resources to the engineering of customized solutions to the most
difficult and novel device challenges. We are excited to bring our absorbable fiber and design
expertise into new and emerging clinical applications with BIOFELT.”
BIOFELT is custom-engineered for individual device requirements and is available in a wide
array of densities and thicknesses to allow for application-specific performance. Proven in
cardiovascular, orthopedic and urological tissue regeneration applications, BIOFELT has been
utilized in everything from internal wound management to hemostasis. As a non-woven fabric,
BIOFELT can be produced as flat sheets, discs, tubes and a variety of other geometric shapes with
an absorption profile from anywhere from less than 30 days to one year.
Biomedical Structures provides advanced design, development and manufacturing of biomedical
textile structures with expertise in knitting, braiding, weaving and non-woven technologies.
The company utilizes a broad offering of biocompatible absorbable and non-absorbable materials in
devices, drug delivery and surgical systems for orthopedic, cardiovascular, bariatric, cosmetic and
veterinary medicine applications.
Posted on January 17, 2012
Source: Biomedical Structures
